The Vaccines Market has demonstrated robust growth, with a valuation of USD 74.73 billion in 2023 and anticipated expansion to USD 168.5 billion by 2031, representing a notable compound annual growth rate (CAGR) of 10.70% during the forecasted period from 2024 to 2031. This trajectory underscores the critical role of vaccines in public health, as they remain one of the most effective tools for preventing infectious diseases. Factors driving market growth include increasing investments in vaccine research and development, expanding vaccination programs globally, and a growing awareness of the importance of immunization in disease prevention. Additionally, the emergence of new infectious diseases and ongoing efforts to combat existing ones, such as the COVID-19 pandemic, further fuel demand for vaccines. As the healthcare industry continues to prioritize disease prevention and immunization strategies, the vaccines market is poised for sustained growth, contributing to improved population health outcomes worldwide.